Endoscopy Devices are medical devices used to examine internal organs for diagnosis and treatment of diseases. Endoscopic Hemostasis Devices consists of devices used in the management of gastrointestinal bleeding and often acts as the first line of therapy. GlobalData uses proprietary data and analytics to provide a comprehensive report on the endoscopic hemostasis devices devices market, including market shares of different players within Canada. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the endoscopic hemostasis devices market in Canada was Boston Scientific followed by Cook Medical, ConMed, Olympus, ERBE Elektromedizin, Micro-Tech Nanjing, United States Endoscopy Group, Diversatek, Medline Industries and Integra LifeSciences.
Endoscopic Hemostasis Devices include Hemostatic Clips, Hemostatic Probes, Disposable Ligator Kits, Reusable Ligators, Injection Needles, and Hemostatic Sprays.
The value of the endoscopic hemostasis devices devices market within Canada was expected to be over $50m in 2023.
For the latest complete market share analysis of endoscopic hemostasis devices device market in Canada, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
